Celldex Therapeutics, Inc. - COM NEW (CLDX)

Historical Portfolio Holders from Q4 2018 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q2 2024
69.6M
Holdings value Q2 2024
$2.58B
Value change Q2 2024
+$1.5M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
179
Number of buys Q2 2024
101
Number of sells Q2 2024
-83
Average buys Q2 2024 %
+0.001%
Average sells Q2 2024 %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 150K $5.11M +$600K $33.99 3
2024 Q2 69.6M $2.58B +$1.5M $37.01 180
2024 Q1 69.3M $2.91B +$363M $41.97 197
2023 Q4 60.1M $2.39B +$394M $39.66 161
2023 Q3 50.6M $1.39B +$5.53M $27.52 141
2023 Q2 50.2M $1.7B +$19.5M $33.93 148
2023 Q1 49.5M $1.78B +$24.1M $35.98 159
2022 Q4 48.7M $2.17B -$9.32M $44.57 162
2022 Q3 49.3M $1.39B +$32.3M $28.11 145
2022 Q2 48.2M $1.3B -$45.7M $26.96 151
2022 Q1 49.6M $1.69B +$106M $34.06 158
2021 Q4 46.3M $1.79B +$97.4M $38.64 170
2021 Q3 43.2M $2.33B +$430M $53.99 157
2021 Q2 35.6M $1.19B +$60.3M $33.44 127
2021 Q1 34.5M $709M -$40.3M $20.60 110
2020 Q4 36.8M $645M +$72.2M $17.52 120
2020 Q3 32.2M $477M +$67.8M $14.83 85
2020 Q2 27.8M $361M +$311M $13.00 63
2020 Q1 3.95M $6.56M +$7.23K $1.66 32
2019 Q4 3.9M $8.7M +$448K $2.23 33
2019 Q3 3.71M $7.89M +$465K $2.13 42
2019 Q2 3.46M $9.28M +$2.11M $2.68 41
2019 Q1 2.6M $12.8M +$12.3M $4.92 39
2018 Q4 100K $20K +$20K $0.20 1